UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ Facultad de Ciencias Químicas. Lab. General Microbiology

Similar documents
Enterobacter aerogenes

European Committee on Antimicrobial Susceptibility Testing

EUCAST recommended strains for internal quality control

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

European Committee on Antimicrobial Susceptibility Testing

What s new in EUCAST methods?

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Antimicrobial Susceptibility Testing: Advanced Course

Detecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Concise Antibiogram Toolkit Background

Available online at ISSN No:

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Prevalence and Susceptibility Profiles of Non-Fermentative Gram-Negative Bacilli Infection in Tertiary Care Hospital

Antibacterial susceptibility testing

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

Aerobic Bacterial Profile and Antimicrobial Susceptibility Pattern of Pus Isolates in a Tertiary Care Hospital in Hadoti Region

What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh

Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital

Understanding the Hospital Antibiogram

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

Antibiotic susceptibility pattern of Pseudomonas aeruginosa at the tertiary care center, Dhiraj Hospital, Piparia, Gujarat

January 2014 Vol. 34 No. 1

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic Updates: Part II

Version 1.01 (01/10/2016)

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

AMR Industry Alliance Antibiotic Discharge Targets

Intrinsic, implied and default resistance

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

Available online at Scholars Research Library. Der Pharmacia Lettre, 2017, 9 (1):85-92

Other Beta - lactam Antibiotics

Antimicrobial Susceptibility Testing: The Basics

Management of Hospital-acquired Pneumonia

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Recommendations to take it forward!

ISSN X (Print) Research Article. *Corresponding author Miss Nazia Shams

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

Approach to pediatric Antibiotics

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Antibiotic Resistance in Pseudomonas aeruginosa Strains Isolated from Various Clinical Specimens

Antimicrobial Therapy

OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Antimicrobial susceptibility

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

BACTERIOLOGICALL STUDY OF MICROORGANISMS ON MOBILES AND STETHOSCOPES USED BY HEALTH CARE WORKERS IN EMERGENCY AND ICU S

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

ESCMID Online Lecture Library. by author

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Levofloxacin and moxifloxacin resistant Haemophilus influenzae in a patient with common variable immunodeficiency (CVID): a case report

Int.J.Curr.Microbiol.App.Sci (2015) 4(9):

Mechanism of antibiotic resistance

Antimicrobial Chemotherapy

Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.

DR. BASHIRU BOI KIKIMOTO

Performance Information. Vet use only

Research Article. Drug resistance pattern of Pseudomonas aeruginosa isolates at PIMS Hospital, Islamabad, Pakistan

Changing Antibiotic sensitivity pattern in Gram Negative Nonfermenting Isolates: a Study in a Tertiary care Hospital

Multidrug-Resistant Acinetobacter

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Pharmacology Week 6 ANTIMICROBIAL AGENTS

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

2015 Antibiotic Susceptibility Report

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections

Isolation, identification and antimicrobial susceptibility pattern of uropathogens isolated at a tertiary care centre

Original Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):

2016 Antibiotic Susceptibility Report

EARS-Net Belgium Data call for 2016: Instructions for participating laboratories, including data definition. (version 4, 20/3/2017)

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

EUCAST-and CLSI potency NEO-SENSITABS

Multidrug-Resistant Gram-Negative Bacterial and Carbapenem-Resistant Enterobacteriaceae Infections in the Department of the Navy: Annual Report 2013

REVOLUTIONARY. MMinimum. BBiofilm EEradication Concentration. inimizing WE HAVE FOUND THE ANSWER.

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002

Transcription:

UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ Facultad de Ciencias Químicas { Lab. General Microbiology Case report: Meningitis caused by Pseudomonas aeruginosa Created by: Ma. Dolores Pacheco Castillo Maestra: Tovar Oviedo Juana Grupo: 8:00-9:00

Associate the knowledge on biochemical test for the identification of microorganism with the clinical importance for diagnosis and treatment in the patient. To know the methods of identification and the specific antibiotic susceptibility of Pseudomonas aeruginosa.

Pseudomonas aeruginosa is a nonfermentative gram negative bacillus. Characterized by the production of pyocyanin. Infection caused by this bacterium have characteristics such as exudation of bluish purulent content and grape-like odor for the production of pyocyanin. It prevails in patients whit burns, cystic fibrosis, leukemia, organ transplants and intravenous drug use. P.Aeruginosa at the microscopy (gramnegative bacillus). www.textbookofbacteriology.net

Clinical Case Craneal magnetic resonance image showing edematous bulb-mesencephalic disease. portalesmedicos.com Male patient with 54 years old,entered at emergency service, reporting vomiting, high fever and neck stiffness with 48 hours of evolution. Lumbar puncture is performed and cerebrospinalñ fluid of turbid aspect with polymorphous predominance is obtained, with presence of (25mg/dL) glucose. The simple is sent to the laboratory for acute bacterial respiratory infections for cultive isolation and study of antibiotic susceptibility.

Metodology It make a cultive of the sample and it isolated Pseudomona aeruginosa and applying biochemical test: oxidase (42 C). It has been made a test OF (oxid-fementation). P. aeruginosa in blood agar.(koneman diagnóstico microbiológico: 2008) It was determinated the sensibility of the strain by the method of disk diffusion. Clinical case Microbiology lab. *Ciprofloxacin *Ceftriaxone *Imipenem *Amikacin *Piperacilin *Aztreonam *Ciprofloxacin *Ampicilin *Ceftriaxone * Acid nalidixic *Trimethoprim/sulphametoxasol

Cytochrome Oxidase Test Identification of: Pseudomonas, Campylobacter and Pasteurella. Method *Take part of the sample and put in a strip filter paper. *Add 2 to 3 drops of reagent. Results Blue coloration after 10 sec. Cytochrome oxidase test, blue color Indicate cytochrome oxidase activity. (Koneman diagnóstico microbiológico: 2008)

OF (Oxide-Fermentation) For microorganism which degrade glucose trough fermentation and oxidation. Components: -peptone 0.2% -carbohydrate 1.0% -agar (semisolid medium) Open tube Covered tube Metabolism Acid (yellow) Alkaline (green) Oxidative Acid (yellow) Acid (yellow) Fermentative Alkaline (green or blue) Alkaline (green or blue) --- OF test: Oxidative reaction characterized by yellow color in the open tube, the green color in the tube 2 remains. (www.textbookofbacteriology.net)

Results Biochemical test Clinical case Oxidase + + (OF) + + Catalase + ------ Microbiology laboratory SIM ----- Movility (+) Production H2S (-) Production Indol (-) Picture 1: results obtained at the laboratory with results obtained in the clinical case. Figure A) Pseudomonas aeruginosa antibiogram, using Ceftadizime (CAZ), Imipenem (IPM), meropenem (MEM), Ciprofloxacin (CIP) and Tobramicina (http://aac.asm.org) Figura B) P. aeruginosa antibiogram using Ciprofloxacin (CIP), Ceftriaxone (CRO), Ampicilin (AM), Ácido nalidíxico(na), Trimethoprim/ sulfamethoxasol (STX). Experimental results. Clinical case susceptibility: ceftriaxone ciprofloxacin imipenem amikacin piperacilin aztreonam Resistance: carbenicillina azocilin gentamicin ticarcillin Microbiology Laboratory susceptibility: ceftriaxone ciprofloxacin Resistance: Trimethoprim/ sulfamethoxasole Ampicilin Acid nalidixic

CIPROFLOXACIN Mechanism: inhibition of topoisomerase IV and bacterial DNA-gyrase. These topoisomerases alter DNA by introducing super.helical folds in double-stranded DNA, facilitating the unwiding of strands. Quinolones inhibit these subunits by preventing replication and transcription of bacterial DNA.

Ampicilin/Amoxicilin Piperacilin Ticarcilin Ampicilin /sulbactam Amoxicilia /clavulanate Piperacilin /tazobactam Cefotaxime Ceftriaxone Ceftadizime Cefepime Aztreonam Imipenem Meropenem Ertapenem Polymyxin B colistin Aminoglycosides Tetracyclines/Trigecyline Trimethoprim Trimehtoprim/sulfametoxasole cloranphenyicol Fosfomycin Attachments Table 1: Antimicrobial agents approved for testing and reporting on organisms by microbiology laboratories. Pseudomonas aeruginosa Group A Ceftadizime Gentamicin Group B Amikacin Aztreonam Cefepime Ciprofloxacin Levofloxacin Tiobramicin piperacilin Imipenem Meropenem Doripenem Piperacilin-tazobactam Table 2. Intrinsec Resistance Antimicrobial Agent Organism Pseudomonas aeruginosa R R R R R R R R R R R

CONCLUSION This results shown in the clinical case have completely coincided whit those obtained in the laboratory, which helps to verify that the procediments mentioned in the bibliography have been correctly performed. Biochemical test for the identification of microorganisms as well as antimicrobial susceptibility test are of great clinical importance, as they allow the identification of the microorganism that causes the pathologies, as well as the selection of the apropiate antibiotic according to its capacity for bacterial inhibition an metabolism of the microorganism causing the disease.

References *Farías Cisneros E, Medina Campos R, Chavarría Garcés J. Neumonía nosocomial por Pseudomonas aeruginosa. Med. Int. Vol. 21 (n 5). Mex; 2005 (acceso 10 de marzo de 2017). Disponible en: new.medigraphic.com/cgi-bin/resumen.cgi?idarticulo=6915 *Clinical and Labortory Standards Institute. M100 Performance Standards for Antimicrobial susceptibility Testing; Twenty-Fifth Informational Supplement. Vol. 35. N 3: 2015(acceso 10 de marzo de 2017). Disponible en: Tzaloa.uaslp.mx *Koneman W, Procop W, Schreckenberger P, Woods L, Janda W, Allen S, etal. Diagnóstico microbiológico. Ed. Médica Panamericana 6 edición. Buenos aires: 2008. Capítulo 7: bacilos gramnegativos no fermentadores pp 301-305. Protocolo 1.2, 1.5, 7.1. págs 1383-1401.